OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer
Mohammad Imran Khan, Abid Hamid, Suvasmita Rath, et al.
Molecular Cancer Therapeutics (2018) Vol. 18, Iss. 2, pp. 356-363
Open Access | Times Cited: 12
Mohammad Imran Khan, Abid Hamid, Suvasmita Rath, et al.
Molecular Cancer Therapeutics (2018) Vol. 18, Iss. 2, pp. 356-363
Open Access | Times Cited: 12
Showing 12 citing articles:
Cancer epigenetics: Past, present and future
Jae Eun Lee, Mi‐Young Kim
Seminars in Cancer Biology (2021) Vol. 83, pp. 4-14
Closed Access | Times Cited: 72
Jae Eun Lee, Mi‐Young Kim
Seminars in Cancer Biology (2021) Vol. 83, pp. 4-14
Closed Access | Times Cited: 72
MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188904-188904
Closed Access | Times Cited: 35
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188904-188904
Closed Access | Times Cited: 35
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway
Yan Li, Lei Tao, Zeping Zuo, et al.
Cancer Letters (2019) Vol. 454, pp. 179-190
Closed Access | Times Cited: 39
Yan Li, Lei Tao, Zeping Zuo, et al.
Cancer Letters (2019) Vol. 454, pp. 179-190
Closed Access | Times Cited: 39
Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
Jung Yoo, Go Woon Kim, Yu Hyun Jeon, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 12, pp. 2107-2117
Open Access | Times Cited: 19
Jung Yoo, Go Woon Kim, Yu Hyun Jeon, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 12, pp. 2107-2117
Open Access | Times Cited: 19
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway
Rong Guo, Liji Shi, Yonghui Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Rong Guo, Liji Shi, Yonghui Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice
Anil Kumar Kalvala, Ramesh Nimma, Arvind Bagde, et al.
Biochimie (2022) Vol. 208, pp. 19-30
Open Access | Times Cited: 15
Anil Kumar Kalvala, Ramesh Nimma, Arvind Bagde, et al.
Biochimie (2022) Vol. 208, pp. 19-30
Open Access | Times Cited: 15
DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway
Dev Karan, Manohar Singh, Seema Dubey, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2763-2763
Open Access | Times Cited: 5
Dev Karan, Manohar Singh, Seema Dubey, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2763-2763
Open Access | Times Cited: 5
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibaşa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Liliana Burlibaşa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Epigenetic Regulation of Chromatin in Prostate Cancer
Ramakrishnan Natesan, Shweta Aras, Samuel Sander Effron, et al.
Advances in experimental medicine and biology (2019), pp. 379-407
Closed Access | Times Cited: 12
Ramakrishnan Natesan, Shweta Aras, Samuel Sander Effron, et al.
Advances in experimental medicine and biology (2019), pp. 379-407
Closed Access | Times Cited: 12
Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner
Yuanyuan Mi, Lifeng Zhang, Chuanyu Sun, et al.
Journal of Cell Communication and Signaling (2022) Vol. 16, Iss. 4, pp. 579-599
Open Access | Times Cited: 4
Yuanyuan Mi, Lifeng Zhang, Chuanyu Sun, et al.
Journal of Cell Communication and Signaling (2022) Vol. 16, Iss. 4, pp. 579-599
Open Access | Times Cited: 4
Molecular profiling of epigenetic landscape of cancer cells during extracellular matrix detachment
Mohammad Imran Khan, Mazin A. Zamzami, Aftab Ahmad, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Mohammad Imran Khan, Mazin A. Zamzami, Aftab Ahmad, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
